IRIS Accounts Production v25.2.0.378 SC190224 Board of Directors 1.12.23 30.11.24 30.11.24 28.8.25 0 0 false true false false true false Auditors Opinion iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWhSC1902242023-11-30SC1902242024-11-30SC1902242023-12-012024-11-30SC1902242022-11-30SC1902242022-12-012023-11-30SC1902242023-11-30SC190224ns15:Scotland2023-12-012024-11-30SC190224ns14:PoundSterling2023-12-012024-11-30SC190224ns10:Director12023-12-012024-11-30SC190224ns10:PrivateLimitedCompanyLtd2023-12-012024-11-30SC190224ns10:SmallEntities2023-12-012024-11-30SC190224ns10:Audited2023-12-012024-11-30SC190224ns10:SmallCompaniesRegimeForDirectorsReport2023-12-012024-11-30SC190224ns10:SmallCompaniesRegimeForAccounts2023-12-012024-11-30SC190224ns10:AbridgedAccounts2023-12-012024-11-30SC190224ns10:Director22023-12-012024-11-30SC190224ns10:RegisteredOffice2023-12-012024-11-30SC190224ns5:CurrentFinancialInstruments2024-11-30SC190224ns5:CurrentFinancialInstruments2023-11-30SC190224ns5:ShareCapital2024-11-30SC190224ns5:ShareCapital2023-11-30
REGISTERED NUMBER: SC190224 (Scotland)















Financial Statements For The Year Ended 30 November 2024

for

MacPharm Limited

MacPharm Limited (Registered number: SC190224)






Contents of the Financial Statements
For The Year Ended 30 November 2024




Page

Company Information 1

Abridged Statement of Financial Position 2

Notes to the Financial Statements 3


MacPharm Limited

Company Information
For The Year Ended 30 November 2024







DIRECTORS: A S Bilon
G A M Stuart





REGISTERED OFFICE: 19a Graham Street
Edinburgh
EH6 5QN





REGISTERED NUMBER: SC190224 (Scotland)





INDEPENDENT AUDITORS: Robb Ferguson
Chartered Accountants & Statutory Auditors
Regent Court
70 West Regent Street
Glasgow
G2 2QZ

MacPharm Limited (Registered number: SC190224)

Abridged Statement of Financial Position
30 November 2024

2024 2023
£    £   
CURRENT ASSETS
Debtors 2 2
Cash at bank 742,225 416,069
742,227 416,071
CREDITORS
Amounts falling due within one year 742,225 416,069
NET CURRENT ASSETS 2 2
TOTAL ASSETS LESS CURRENT
LIABILITIES

2

2

CAPITAL AND RESERVES
Called up share capital 2 2
SHAREHOLDERS' FUNDS 2 2

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

All the members have consented to the preparation of an abridged Statement of Comprehensive Income and an abridged Statement of Financial Position for the year ended 30 November 2024 in accordance with Section 444(2A) of the Companies Act 2006.

In accordance with Section 444 of the Companies Act 2006, the Statement of Comprehensive Income has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 27 August 2025 and were signed on its behalf by:





A S Bilon - Director


MacPharm Limited (Registered number: SC190224)

Notes to the Financial Statements
For The Year Ended 30 November 2024

1. STATUTORY INFORMATION

MacPharm Limited is a private company, limited by shares , registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Related party exemption
The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

Financial instruments
Basic financial instruments are recognised at amortised cost, except for investments in non-convertible preference and non-puttable ordinary shares which are measured at fair value, with changes recognised in profit or loss. Derivative financial instruments are initially recorded at cost and thereafter at fair value with changes recognised in profit or loss.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2023 - NIL).

4. DISCLOSURE UNDER SECTION 444(5B) OF THE COMPANIES ACT 2006

The Report of the Auditors was unqualified.

Graham Cantlay (Senior Statutory Auditor)
for and on behalf of Robb Ferguson

MacPharm Limited (Registered number: SC190224)

Notes to the Financial Statements - continued
For The Year Ended 30 November 2024

5. ULTIMATE PARENT COMPANY

GAM Stuart Ltd is regarded by the directors as being the company's ultimate parent company.

6. ULTIMATE CONTROLLING PARTY

The ultimate controlling parties are G A M Stuart and A S Bilon by virtue of their majority shareholding of GAM Stuart Ltd.